On the public citation graph
Private Coverage of Methadone in Outpatient Treatment Programs
0 signed · 23 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1056/nejmp1803982openalex-snapshot
Methadone in Primary Care — One Small Step for Congress, One Giant Leap for Addiction Treatment
inferredcites →https://doi.org/10.1080/02791072.2017.1300360openalex-snapshot
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014
inferredcites →https://doi.org/10.1111/j.1525-1497.2005.04028.xopenalex-snapshot
Methadone medical maintenance in primary care
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.5852openalex-snapshot
Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.18223openalex-snapshot
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada
inferred← citeshttps://doi.org/10.1002/9781394263752.ch11openalex-snapshot
Advancing Mental Health Equity Through Policies
inferred← citeshttps://doi.org/10.1002/pam.70106openalex-snapshot
Insurance Coverage and Provision of Opioid Disorder Treatment: Evidence From Medicare
inferred← citeshttps://doi.org/10.1007/s11606-021-07094-9openalex-snapshot
Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108764openalex-snapshot
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209022openalex-snapshot
The Role of Health Plans in Addressing the Opioid Crisis: A Qualitative Study
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209193openalex-snapshot
Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S.
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209441openalex-snapshot
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application
inferred← citeshttps://doi.org/10.1016/j.josat.2026.210014openalex-snapshot
Trends in Medicaid managed care benefits for opioid use disorder treatment, 2015–2019
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108329openalex-snapshot
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108384openalex-snapshot
Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108533openalex-snapshot
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation
inferred← citeshttps://doi.org/10.1093/haschl/qxae024openalex-snapshot
US payment policy for medications to treat opioid use disorder: landscape and opportunities
inferred← citeshttps://doi.org/10.1377/hlthaff.2025.00253openalex-snapshot
Medicaid Enrollees With Opioid Use Disorder Were More Likely To Receive Medication Treatment Than Commercial Enrollees
inferred← citeshttps://doi.org/10.2105/ajph.2021.306577openalex-snapshot
Self-Reported Treatment Need and Barriers to Care for Adults With Opioid Use Disorder: The US National Survey on Drug Use and Health, 2015 to 2019
inferred← citeshttps://doi.org/10.2105/ajph.2022.306806openalex-snapshot
Federal and State Regulatory Changes to Methadone Take-Home Doses: Impact of Sociostructural Factors
inferred← citeshttps://doi.org/10.3386/w31884openalex-snapshot
Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare
inferred← citeshttps://doi.org/10.37765/ajmc.2022.89250openalex-snapshot
The Impact of HDHPs on Service Use and Spending for Substance Use Disorders
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.